Oppenheimer & Co. Inc. Cuts Stock Position in Kenvue Inc. $KVUE

Oppenheimer & Co. Inc. lessened its stake in Kenvue Inc. (NYSE:KVUE) by 49.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 127,811 shares of the company’s stock after selling 124,355 shares during the period. Oppenheimer & Co. Inc.’s holdings in Kenvue were worth $2,205,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of Kenvue by 27.1% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 310,686 shares of the company’s stock worth $5,042,000 after buying an additional 66,192 shares during the last quarter. Allstate Corp bought a new stake in shares of Kenvue in the third quarter worth $1,152,000. Aberdeen Group plc increased its stake in shares of Kenvue by 84.1% in the third quarter. Aberdeen Group plc now owns 1,411,380 shares of the company’s stock worth $22,914,000 after buying an additional 644,930 shares during the last quarter. Oak Thistle LLC bought a new stake in shares of Kenvue in the fourth quarter worth $1,563,000. Finally, Eubel Brady & Suttman Asset Management Inc. increased its stake in shares of Kenvue by 39.7% in the third quarter. Eubel Brady & Suttman Asset Management Inc. now owns 1,371,886 shares of the company’s stock worth $22,266,000 after buying an additional 389,704 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on KVUE shares. UBS Group dropped their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Argus upgraded shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Canaccord Genuity Group boosted their target price on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Wednesday, February 18th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a research note on Wednesday, April 8th. Finally, Barclays lowered their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Three equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $19.33.

Kenvue Stock Performance

KVUE stock opened at $17.15 on Tuesday. The company has a market capitalization of $32.92 billion, a P/E ratio of 22.27, a PEG ratio of 3.96 and a beta of 0.55. The company has a 50-day simple moving average of $17.72 and a 200 day simple moving average of $17.19. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.26 earnings per share. Sell-side analysts predict that Kenvue Inc. will post 1.1 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be issued a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue’s dividend payout ratio is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.